ARCHIVES

FDA Continues Bureaucratic Delays Of Cancer INDs

This article is from The Cancer Letter archive.

Vol. 02 No. 05 | January 30, 1976

Download PDF Visit The Full Archive

Related Articles

Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer

October 25, 2021

Funding Opportunity: Leukemia & Lymphoma Society Launches Myeloid Program

October 31, 2014

Biomedical Panel To Hear Public At Sept. Meeting

July 11, 1975

Guest Editorial: As ACS Turns 100, Society President Calls For Tools To Finish the Fight Against Cancer

May 17, 2013

Also Weber returns to M.D. Anderson.

August 8, 2003

NCI-Approved Cancer Center, Cooperative Group Trials

April 27, 2007